Corvus Pharmaceuticals: A New Immunotherapy Player – Seeking Alpha
|
Corvus Pharmaceuticals: A New Immunotherapy Player
Seeking Alpha The company expects to start a pivotal trial in renal cell carcinoma in the second half of the year. Many large biotech companies have shown interest in targeting the adenosine pathway. The immune checkpoints are signaling molecules that act to shut … |
